This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia. The contract has a firm fixed price of $6,272.28 and a completion date of November 12, 2024. The award is not designated as a set-aside contract, indicating open competition. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/27/25, 12:11 PM